ADB’s Rapid COVID-19 Response in Southeast Asia
ADB has approved $5.813 billion in financing to help Southeast Asian countries cope with the devastating impacts of the pandemic. This support focuses on three key areas: boosting healthcare responses, enhancing social protection, and protecting businesses and economies. Recent assistance to Indonesia and the Philippines was also provided to support COVID-19 vaccine procurement and distribution under ADB’s Asia Pacific Vaccine Access Facility (APVAX).
The brochure provides details on how and where this assistance is being rolled out and includes country-specific examples. It also looks at ADB’s collaboration with the private sector and development partners, and the complementary support being provided through its knowledge and policy advice services.